These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 14154337)
1. [ON THE ACTIVITY OF CERULOPLASMIN IN NEUROLOGIC AND PSYCHIATRIC DISORDERS WITH SPECIAL REFERENCE TO MULTIPLE SCLEROSIS]. FISCH G Confin Neurol; 1964; 24():257-80. PubMed ID: 14154337 [No Abstract] [Full Text] [Related]
2. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE. WALSHE JM Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274 [No Abstract] [Full Text] [Related]
3. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease). SCHEINBERG IH Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521 [No Abstract] [Full Text] [Related]
4. [AMINOACIDURIAS IN PATIENTS WITH PSYCHIATRIC DISORDERS AND OTHER RELATED STATES]. CHEDIDTURBAY A Med Trop (Madr); 1964; 40():36-87. PubMed ID: 14132714 [No Abstract] [Full Text] [Related]
5. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease. SCHEINBERG IH; MORELL AG J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081 [No Abstract] [Full Text] [Related]
6. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429 [No Abstract] [Full Text] [Related]
7. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin]. Wald I; Galewicz A; Górska D Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660 [No Abstract] [Full Text] [Related]
8. Investigations of some physio-biochemical properties of ceruloplasmin in schizophrenics and in normal subjects. Puzyński S; Kalinowski A Nature; 1966 Oct; 212(5060):399-400. PubMed ID: 5970147 [No Abstract] [Full Text] [Related]
9. [CERULOPLASMIN CONTENT IN PATIENTS WITH HEPATOCEREBRAL DYSTROPHY AND IN THEIR HEALTHY RELATIVES]. MITTELSHTEDT AA; BAUMAN LK Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():819-21. PubMed ID: 14235907 [No Abstract] [Full Text] [Related]
10. CHROMATOGRAPHIC AND MAGNETIC STUDIES ON HUMAN CERULOPLASMIN. BROMAN L Acta Soc Med Ups; 1964; 69():SUPPL 7:1-85. PubMed ID: 14229509 [No Abstract] [Full Text] [Related]
12. [COPPER METABOLISM AND WILSON'S DISEASE]. LANGE J Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237 [No Abstract] [Full Text] [Related]
13. [Indices of blood copper content and ceruloplasmin activity of the blood in patients with cerebral circulatory disorders]. Krichun IIa Vrach Delo; 1972 Apr; 4():23-4. PubMed ID: 5048943 [No Abstract] [Full Text] [Related]
14. [The role of ceruloplasmin in the differential diagnosis of neuropsychiatric disorders]. Connemann BJ; Schönfeldt-Lecuona C; Maxon HJ; Kratzer W; Kassubek J Fortschr Neurol Psychiatr; 2010 Oct; 78(10):582-9. PubMed ID: 20812166 [TBL] [Abstract][Full Text] [Related]
15. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION]. AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395 [No Abstract] [Full Text] [Related]
16. Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper. MORELL AG; SCHEINBERG IH Science; 1958 Mar; 127(3298):588-90. PubMed ID: 13529022 [No Abstract] [Full Text] [Related]